A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases

Annals of Surgical Oncology

Volumn 21, Issue 6, 2014, Pages 2052-2058

  Elias, Dominique ^a   Faron, Matthieu ^a   Goéré, Diane ^a   Dumont, Frédéric ^a   Honoré, Charles ^a   Boige, Valérie ^a   Malka, David ^a   Ducreux, Michel ^a  

^a Department of Oncologic Surgery Gustave Roussy ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; COLORECTAL CANCER; COLORECTAL METASTASIS; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NOMOGRAM; OVERALL SURVIVAL; PERITONEUM METASTASIS; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; CATHETER ABLATION; CHILD; COLORECTAL TUMOR; CYTOREDUCTIVE SURGERY; HYPERTHERMIC THERAPY; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PERITONEAL NEOPLASMS; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; SECONDARY; SURVIVAL RATE; TUMOR VOLUME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HEPATECTOMY; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NOMOGRAMS; PERITONEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 84902189245     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3506-z     Document Type: Article

References (21)

1. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91-103.
2. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63-8.
3. Elias D, Lefèvre J, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681-5.
4. Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach ? Lancet Oncol. 2012;13:362-9.
5. Kattan MW, Gönen M, Jarnagin WR, De Matteo R, D'Angelica M, Weiser M, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:282-7.
6. Kanemitsu Y, Kato T. Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg. 2008;32:1097-107.
7. Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2012;19:72-84.
8. Takakura Y, Okajima M, Kanemitsu Y, Kuroda S, Egi H, Hinoi T, et al. External validation of two nomograms for predicting patient survival after hepatic resection of metastatic colorectal cancer. World J Surg. 2011;35:2275-82.
9. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg. 2003;90:567-74.
10. Pulitano C, Bodingbauer M, Aldrighetti L, de Jong MC, Castillo F, Schulick RD, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol. 2011;18:1380-8.
11. Carpizo DR, Are C, Jarnagin W, Dematteo R, Fong Y, Gönen M, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol. 2009;16:2138-46.
12. Adam R, de Haas RJ, Wicherts DA, Vibert E, Salloum C, Azoulay D, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg. 2011;253:349-59.
13. Maggiori L, Goére D, Viana B, Tzanis D, Dumont F, Honoré C, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastasis be treated with a curative intent? Ann Surg. 2013;258:116-21.
14. Elias D. Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery? Ann Surg Oncol. 2004;11:122-3.
15. Shen P, Thai K, Stewart JH, Howerton R, Loggie BW, Russell GB, et al. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol. 2008;15:3422-32.
16. Cao CQ, Yan TD, Liauw W, Morris DL. Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastases. J Surg Oncol. 2009;100:529-33.
17. Elias D, Faron M, Stan Iuga B, Honoré C, Dumont F, Ducreux M, et al. Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers. Ann Surg. 2014 (in press).
18. Elias D, Lasser P, Debaene B, Doidy L, Billard V, Spencer A, et al. Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy. Br J Surg. 1995;82:1535-9.
19. Elias D, de Baere T, Muttillo I, Cavalcanti A, Coyle C, Roche A. Intra-operative use of radiofrequency allows an increase in the rate of curative liver resection. J Surg Oncol. 1998;67:190-1.
20. da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg. 2006;203:878-86.
21. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92:71-6.